DK4025691T3 - Nye, ikke naturligt forekommende CRISPR-Cas-nukleaser til genomeditering - Google Patents
Nye, ikke naturligt forekommende CRISPR-Cas-nukleaser til genomeditering Download PDFInfo
- Publication number
- DK4025691T3 DK4025691T3 DK21765836.8T DK21765836T DK4025691T3 DK 4025691 T3 DK4025691 T3 DK 4025691T3 DK 21765836 T DK21765836 T DK 21765836T DK 4025691 T3 DK4025691 T3 DK 4025691T3
- Authority
- DK
- Denmark
- Prior art keywords
- naturally occurring
- genome editing
- novel non
- occurring crispr
- cas nucleases
- Prior art date
Links
- 101710163270 Nuclease Proteins 0.000 title 1
- 238000010362 genome editing Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8213—Targeted insertion of genes into the plant genome by homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20000262 | 2020-07-21 | ||
| EP20000329.1A EP3943600A1 (en) | 2020-07-21 | 2020-09-10 | Novel, non-naturally occurring crispr-cas nucleases for genome editing |
| PCT/EP2021/000081 WO2022017633A2 (en) | 2020-07-21 | 2021-07-20 | Novel, non-naturally occurring crispr-cas nucleases for genome editing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4025691T3 true DK4025691T3 (da) | 2023-10-30 |
Family
ID=71783795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21765836.8T DK4025691T3 (da) | 2020-07-21 | 2021-07-20 | Nye, ikke naturligt forekommende CRISPR-Cas-nukleaser til genomeditering |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230287372A1 (da) |
| EP (3) | EP3943600A1 (da) |
| JP (1) | JP2023535064A (da) |
| KR (1) | KR20230041687A (da) |
| CN (1) | CN116134133A (da) |
| AU (1) | AU2021311773A1 (da) |
| BR (1) | BR112022026311A2 (da) |
| CA (1) | CA3189525A1 (da) |
| DK (1) | DK4025691T3 (da) |
| ES (1) | ES2963187T3 (da) |
| FI (1) | FI4025691T3 (da) |
| IL (1) | IL299990B2 (da) |
| PL (1) | PL4025691T3 (da) |
| WO (1) | WO2022017633A2 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL305545A (en) * | 2021-03-02 | 2023-10-01 | BRAIN Biotech AG | Novel CRISPR-CAS nucleases from metagenomics |
| IL314363A (en) * | 2022-01-19 | 2024-09-01 | BRAIN Biotech AG | Cell dilution by CRISPR nucleases |
| EP4215611A1 (en) | 2022-01-19 | 2023-07-26 | BRAIN Biotech AG | Modification of the genome of a filamentous fungus |
| EP4215612A1 (en) | 2022-01-20 | 2023-07-26 | Sartorius Stedim Cellca GmbH | Genome editing with crispr/cas nucleases comprising collateral activity |
| EP4361265A1 (en) * | 2022-10-27 | 2024-05-01 | BRAIN Biotech AG | Optimization of editing efficacy of crispr nucleases with collateral activity |
| WO2024133937A1 (en) * | 2022-12-22 | 2024-06-27 | Biotalys NV | Methods for genome editing |
| WO2024146916A1 (en) | 2023-01-04 | 2024-07-11 | BRAIN Biotech AG | Activated bec nucleases for degrading nucleic acid molecules |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015891A (en) | 1988-09-09 | 2000-01-18 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene having a modified frequency of codon usage |
| US5364780A (en) | 1989-03-17 | 1994-11-15 | E. I. Du Pont De Nemours And Company | External regulation of gene expression by inducible promoters |
| US20030167526A1 (en) | 2002-01-14 | 2003-09-04 | Pioneer Hi-Bred International Inc. | Compositions and methods for identifying transformed cells |
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| US9896696B2 (en) | 2016-02-15 | 2018-02-20 | Benson Hill Biosystems, Inc. | Compositions and methods for modifying genomes |
| US20180362590A1 (en) * | 2017-04-14 | 2018-12-20 | Synthetic Genomics, Inc. | Polypeptides with type v crispr activity and uses thereof |
| CN111373040B (zh) | 2017-08-09 | 2024-07-12 | 本森希尔股份有限公司 | 修饰基因组的组合物和方法 |
-
2020
- 2020-09-10 EP EP20000329.1A patent/EP3943600A1/en not_active Ceased
-
2021
- 2021-07-20 WO PCT/EP2021/000081 patent/WO2022017633A2/en unknown
- 2021-07-20 JP JP2023504539A patent/JP2023535064A/ja active Pending
- 2021-07-20 CA CA3189525A patent/CA3189525A1/en active Pending
- 2021-07-20 DK DK21765836.8T patent/DK4025691T3/da active
- 2021-07-20 EP EP21765836.8A patent/EP4025691B1/en active Active
- 2021-07-20 CN CN202180059698.2A patent/CN116134133A/zh active Pending
- 2021-07-20 FI FIEP21765836.8T patent/FI4025691T3/fi active
- 2021-07-20 AU AU2021311773A patent/AU2021311773A1/en active Pending
- 2021-07-20 PL PL21765836.8T patent/PL4025691T3/pl unknown
- 2021-07-20 KR KR1020237001407A patent/KR20230041687A/ko unknown
- 2021-07-20 IL IL299990A patent/IL299990B2/en unknown
- 2021-07-20 ES ES21765836T patent/ES2963187T3/es active Active
- 2021-07-20 BR BR112022026311A patent/BR112022026311A2/pt unknown
- 2021-07-20 EP EP23196032.9A patent/EP4279597A3/en active Pending
- 2021-07-20 US US18/006,324 patent/US20230287372A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023535064A (ja) | 2023-08-15 |
| EP4279597A2 (en) | 2023-11-22 |
| CA3189525A1 (en) | 2022-01-27 |
| FI4025691T3 (fi) | 2023-11-06 |
| ES2963187T3 (es) | 2024-03-25 |
| EP4025691A2 (en) | 2022-07-13 |
| WO2022017633A3 (en) | 2022-03-10 |
| US20230287372A1 (en) | 2023-09-14 |
| EP3943600A1 (en) | 2022-01-26 |
| IL299990B2 (en) | 2024-10-01 |
| PL4025691T3 (pl) | 2024-04-08 |
| WO2022017633A8 (en) | 2022-04-07 |
| KR20230041687A (ko) | 2023-03-24 |
| CN116134133A (zh) | 2023-05-16 |
| BR112022026311A2 (pt) | 2023-01-31 |
| IL299990A (en) | 2023-03-01 |
| AU2021311773A8 (en) | 2023-03-09 |
| WO2022017633A2 (en) | 2022-01-27 |
| EP4025691B1 (en) | 2023-09-13 |
| EP4279597A3 (en) | 2024-04-24 |
| AU2021311773A1 (en) | 2023-02-23 |
| IL299990B1 (en) | 2024-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK4025691T3 (da) | Nye, ikke naturligt forekommende CRISPR-Cas-nukleaser til genomeditering | |
| CL2018000902A1 (es) | Edición de genoma multiplexado. | |
| EA201891532A1 (ru) | Композиции и способы лечения гемоглобинопатий | |
| BR112018011089A2 (pt) | composições e métodos para a imuno-oncologia | |
| EA201891211A1 (ru) | Ингибиторы cxcr2 | |
| EP3469084A4 (en) | HIGHLY SPECIFIC GENOMEDITATION BY CHEMICALLY MODIFIED GUIDE RNAS | |
| FR3042506B1 (fr) | Outil genetique de transformation de bacteries clostridium | |
| EA201690403A1 (ru) | Композиции и способы для модулирования рнк | |
| DK3580211T3 (da) | 2-heteroaryl-3-oxo-2,3-dihydropyridazin-4-carboxamider til behandling af cancer | |
| EP3456825A4 (en) | METHOD FOR PLANT GENE EDITING | |
| DK2882442T3 (da) | Fremgangsmåder til behandling af cancer under anvendelse af 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin-2,6-dion | |
| UY34559A (es) | Inhibidores de bromodominios | |
| IT201600117287A1 (it) | Metodo di trasfezione transiente per produzione retrovirale. | |
| EA201992232A1 (ru) | Композиции и способы для иммуноонкологии | |
| DK3790927T3 (da) | Fremgangsmåde, indretning og anvendelse til oparbejdning af i det væsentlige polyalkylenterephthalat | |
| MA42597A (fr) | 2-amino-3-fluoro-3-(fluorométhyl)-6-méthyl-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 | |
| BR112015000869A2 (pt) | derivação de contexto de unidade de transformação baseada em tamanho. | |
| EP3501638A4 (en) | SUPPORTED CATALYST USED FOR SYNTHESIZING POLYETHER AMINE, AND MANUFACTURING METHOD | |
| BR112017023225A2 (pt) | inibidor de proteína cinase | |
| DK3100511T3 (da) | Understøtning mellem netværk, der opererer i henhold til forskellige radioadgangsteknologier | |
| DK3415473T3 (da) | Skæresystem for plader | |
| ITUB20161235A1 (it) | Irroratrice, soprattutto per frutteti. | |
| DK3092223T3 (da) | (r)-3-((3s,4s)-3-fluor-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4- methylbenzyl)pyrrolidin-2-on og prodrugs heraf til behandling af psykiatriske forstyrrelser | |
| DK3923914T3 (da) | Afabicin-formulering, fremgangsmåde til fremstilling deraf | |
| IT201600132658A1 (it) | Impianto di caricamento mobile per betoniere |